Fig. 3 | British Journal of Cancer

Fig. 3

From: Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences

Fig. 3

Kaplan–Meier analyses for recurrence-free interval in ER-positive, HER2-negative breast cancer patients according to tamoxifen treatment and (a) patients assigned to group FALSE (corresponding to the preferentially not activated heatmap group N) by use of our classification tool; and (b) patients assigned to group TRUE (corresponding to the preferentially activated heatmap group A) by use of our classification tool. The interrupted line specifies patients treated with tamoxifen. The continuous line shows patients randomised to the control arm

Back to article page